These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 5710247)

  • 21. [Th 13-14 and PZA and CS in the treatment of chronic cavitary tuberculosis with bacterial resistance to classic antibacterial drugs].
    Zunić D
    Tuberkuloza; 1966; 18(5):429-40. PubMed ID: 16296047
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of second line drugs in patients with drug resistance to standard tuberculostatics.
    Zierski M
    Dis Chest; 1968 Apr; 53(4):421-6. PubMed ID: 5652478
    [No Abstract]   [Full Text] [Related]  

  • 23. The management of drug-resistant pulmonary tuberculosis.
    Pines A
    Br J Dis Chest; 1968 Jan; 62(1):1-10. PubMed ID: 4872326
    [No Abstract]   [Full Text] [Related]  

  • 24. Modern treatment of tuberculosis.
    Dutt AK; Stead WW
    Compr Ther; 1982 Sep; 8(9):19-28. PubMed ID: 7140206
    [No Abstract]   [Full Text] [Related]  

  • 25. The problem of the chronic excretor of tubercle bacilli.
    Stýblo K; Kubík A; Langerová M; Matusková E; Morávková K
    Scand J Respir Dis; 1968; 49(3):236-48. PubMed ID: 4309247
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of patients with drug-resistance in economically developed countries.
    Crofton J
    Tubercle; 1969 Mar; 50():Suppl:65-8. PubMed ID: 4319134
    [No Abstract]   [Full Text] [Related]  

  • 27. Experimental "in vivo" studies of new antituberculosis drugs: capreomycin, ethambutol, rifampicin.
    Grumbach F
    Tubercle; 1969 Mar; 50():Suppl:12-21. PubMed ID: 5402543
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical experience with ethambutol.
    Wilson TM
    Antibiot Chemother; 1970; 16():222-9. PubMed ID: 4108890
    [No Abstract]   [Full Text] [Related]  

  • 29. [Intermittent long-term cheomotherapy in experimental tuberculosis of the mouse].
    Grumbach F
    Bull Int Union Tuberc; 1968 Dec; 41():303-8. PubMed ID: 5710255
    [No Abstract]   [Full Text] [Related]  

  • 30. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study of biweekly streptomycin and isoniazid with daily P.A.S. and isoniazid regimens in the treatment of pulmonary tuberculosis.
    Mathur JB; Bahadur P; Agnihotri CB
    J Indian Med Assoc; 1967 Aug; 49(4):162-5. PubMed ID: 5594009
    [No Abstract]   [Full Text] [Related]  

  • 32. [Urgent problems of antibacterial treatment of pulmonary tuberculosis].
    Pilipchuk NS
    Vrach Delo; 1981 Jan; (1):47-9. PubMed ID: 7010782
    [No Abstract]   [Full Text] [Related]  

  • 33. Intermittent chemotherapy.
    Tubercle; 1967 Mar; 48(1):58-61. PubMed ID: 4166513
    [No Abstract]   [Full Text] [Related]  

  • 34. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The John Barnwell Lecture. Changing concepts in the chemotherapy of pulmonary tuberculosis.
    Fox W
    Am Rev Respir Dis; 1968 May; 97(5):767-90. PubMed ID: 4171718
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparison of regimens of ethionamide, pyrazinamide and cycloserine in re-treatment of patients with pulmonary tuberculosis.
    Bignall JR
    Bull Int Union Tuberc; 1968 Dec; 41():175-7. PubMed ID: 4885379
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intermittent chemotherapy of pulmonary tuberculosis].
    Fox W
    Dtsch Med J; 1971 Jan; 22(1):22-7. PubMed ID: 4994246
    [No Abstract]   [Full Text] [Related]  

  • 38. [Autonomic drug therapy with delayed action drugs in pulmonary tuberculosis (chronic-drug therapy resistant patients, without immediate surgical possibilities)].
    Bethlem N; Mendes W
    Hospital (Rio J); 1968 Jul; 74(1):1-5. PubMed ID: 5305552
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis].
    Kawakami K
    Kekkaku; 2002 Aug; 77(8):569-71. PubMed ID: 12235849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect and treatment problems of secondary antitubercular agents].
    Dissmann E
    Wien Med Wochenschr; 1966 Nov; 116(47):996-8. PubMed ID: 6011782
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.